Nalaganje...
Biosimilars as a Future, Promising Solution for Financial Toxicity: A Review with Emphasis on Bevacizumab
A biosimilar is a biochemical product like another already approved biologic agent, known as the reference agent. To be endorsed by the Food and Drug Administration (FDA), biosimilars must demonstrate that they are as safe and effective as their reference item, with no clinical distinction. Humanize...
Shranjeno v:
| izdano v: | Cureus |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cureus
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437115/ https://ncbi.nlm.nih.gov/pubmed/32832297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9300 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|